Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending August 2011. The report details a specific corporate action regarding the repurchase and cancellation of the company's ordinary shares, executed under shareholder authority granted at the Annual General Meeting on May 5, 2011.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share capital transactions.
- Shares Repurchased: 2,300,000 ordinary shares of 25 pence each.
- Transaction Date: August 9, 2011.
- Price Range: Highest price paid was 1,238 pence per share; lowest price paid was 1,160 pence per share.
- Treasury Shares Held: 502,996,816 shares (representing 8.97% of total issued share capital and 9.86% of total voting rights).
- Shares in Issue: 5,102,265,083 shares (excluding Treasury shares).
Material Changes
The primary material change reported is the reduction of the company's issued share capital through the cancellation of 2,300,000 repurchased shares. Consequently, the total number of shares in issue was adjusted to 5,102,265,083. The filing does not provide comparative data against a prior period for financial performance.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a compliance announcement confirming conformity with the Financial Services Authority's Disclosure and Transparency Rules and explicitly states it does not constitute an offer or solicitation to purchase securities.
Investor Verification Checklist
- Verify the updated total issued share capital of 5,102,265,083 shares for calculating ownership thresholds under Disclosure and Transparency Rules.
- Confirm the total Treasury share holding of 502,996,816 shares and its impact on voting rights (9.86%).
- Note that this filing does not contain quarterly or annual financial results; investors should refer to Form 20-F or other periodic reports for revenue and profit data.